Cargando…
P15: EVOLUTION OF MULTIPLE MYELOMA TREATMENT PATTERNS FROM 2015 THROUGH 2019: REAL-WORLD EVIDENCE FROM A EUROPEAN DATABASE STUDY
Autores principales: | Oriol Rocafiguera, A, Steinmetz, T H, Brescianini, A, Gonzalez-McQuire, S, Eugene, N, Abbasi, A, Wetten, S, Leleu, X |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009787/ http://dx.doi.org/10.1097/01.HS9.0000829632.52535.d2 |
Ejemplares similares
-
P24: EXPERT PERSPECTIVES OF UNMET NEED IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) WHO RECEIVE LENALIDOMIDE-SPARING REGIMENS IN EUROPE
por: Mateos, M, et al.
Publicado: (2022) -
Understanding mortality in multiple myeloma: Findings of a European retrospective chart review
por: Mohty, Mohamad, et al.
Publicado: (2019) -
Real‐world use of carfilzomib combined with lenalidomide and dexamethasone in patients with multiple myeloma in Europe and Israel
por: Leleu, Xavier, et al.
Publicado: (2022) -
Real-World Use and Effectiveness of Carfilzomib Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma in Europe
por: Terpos, Evangelos, et al.
Publicado: (2022) -
Association between cigarette smoking status and voting intentions: Cross sectional surveys in England 2015-2020
por: Cox, Sharon, et al.
Publicado: (2021)